Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal infection and immunization in children

C J Lee1, T R Wang

  • 1Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892.

Critical Reviews in Microbiology
|January 1, 1994
PubMed
Summary

Pneumococcal conjugate vaccines with inactivated pneumolysin show promise for protecting young children. Enhancing vaccine immunogenicity is key to preventing serious pneumococcal diseases in vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic Temporal Modeling of Abdominal Aortic Aneurysm Morphology with Z-SINDy.

medRxiv : the preprint server for health sciences·2026
Same author

Increasing Rates of Esophageal Stricture and Dilation Over 2 Decades in Eosinophilic Esophagitis.

Gastro hep advances·2023
Same author

New <i>ABO</i> intron 1 variant alleles.

Immunohematology·2021
Same author

Correction: Astrocytic water channel aquaporin-4 modulates brain plasticity in both mice and humans: a potential gliogenetic mechanism underlying language-associated learning.

Molecular psychiatry·2021
Same author

High-Resolution X-ray Photoelectron Spectroscopy of an IrO<sub>2</sub>(110) Film on Ir(100).

The journal of physical chemistry letters·2020
Same author

Molecular chemisorption of N<sub>2</sub> on IrO<sub>2</sub>(110).

The Journal of chemical physics·2020

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Pneumococcal infections cause significant pediatric diseases like meningitis, pneumonia, and bacteremia.
  • Young children under two years old are most susceptible to severe pneumococcal infections.
  • Specific pneumococcal serotypes are responsible for the majority of pediatric disease cases.

Purpose of the Study:

  • To evaluate the protective immunity conferred by pneumococcal polysaccharide (PS)-protein conjugates containing inactivated pneumolysin in young mice.
  • To investigate the impact of PS molecular size on antibody response in conjugate vaccines.
  • To explore strategies for enhancing the immunogenicity of pneumococcal vaccines for young children.

Main Methods:

  • Young mice were immunized with pneumococcal type 9V PS conjugated to inactivated pneumolysin.
  • Bacterial clearance and antibody responses were assessed post-immunization.
  • The effect of molecular size of pneumococcal type 19F PS in conjugate preparation on antibody response was examined.

Main Results:

  • Pneumococcal PS-protein conjugate vaccination conferred protective immunity against pneumococcal infection in young mice.
  • Inactivated pneumolysin as a PS-protein conjugate enhanced vaccine efficacy.
  • Conjugates prepared with larger molecular weight 19F PS elicited a higher antibody response.

Conclusions:

  • Pneumococcal PS-protein conjugate vaccines, potentially including inactivated pneumolysin, can induce protective immunity.
  • The molecular size of PS is critical for achieving a robust antibody response in conjugate vaccines.
  • Developing improved conjugate vaccines is essential to overcome the poor immunogenicity of traditional pneumococcal vaccines in infants.

Related Experiment Videos